HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA

Drug-induced Parkinsonism

Drug-induced Parkinsonism

Drug-induced Parkinsonism is a neurological disorder caused by the long-term use of certain medications, mostly those used to treat psychiatric disorders. Although this condition can lead to some of the same problems that are symptomatic of Parkinson’s disease, it is actually considered a separate illness. The symptoms of drug-induced Parkinsonism can range from mild to severe and are closely related to the doses and type of medication taken. One of the most common medications associated with drug-induced Parkinsonism is antipsychotic drugs. These medications are often prescribed to treat mental health disorders such as schizophrenia, bipolar disorder, and major depressive disorder. Common antipsychotic medications that can lead to drug-induced Parkinsonism include haloperidol, chlorpromazine, and methyldopa. Other medications, such as anti-nausea drugs, can also induce the condition. The most common symptoms of drug-induced Parkinsonism are similar to those of Parkinson’s disease: tremors, slow movement, rigid muscles, postural instability, and impaired gait. Patients may also experience changes in behavior and mood, as well as cognitive decline. Due to the similarity of symptoms, the two conditions can be difficult to distinguish. In order to diagnose drug-induced Parkinsonism, doctors will need to review a patient’s medical history and medications. Additionally, imaging scans such as magnetic resonance imaging (MRI) and computed tomography (CT) scans may be done to look for signs of the disorder. Once the diagnosis has been made, the doctor may recommend discontinuing the medication that is causing the symptoms or replacing it with a lower-risk medication. The prognosis for drug-induced Parkinsonism is largely dependent on the underlying cause, specific symptoms, and the medication being taken. With the discontinuation of the medication or the use of an alternative, the symptoms can often improve or resolve over time. However, if the symptoms are severe and the underlying cause is not addressed, the disorder can become chronic and treatment options may be limited. It is important to take medications as prescribed and be mindful of any changes in behavior or motor skills that may result from their use. If there is any concern over possible drug-induced Parkinsonism, patients should speak with their doctor as soon as possible. With the right diagnosis and treatment approach, people with the condition can successfully manage their symptoms and prevent further complications.

Committee Members
Speaker at Neuroscience Conference - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia
Speaker at Neurology and Brain Disorders - Joe Sam Robinson

Joe Sam Robinson

Mercer University, United States
Speaker at Neurology Conferences - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
INBC 2025 Speakers
Speaker at Brain Disorders Conference - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Neuroscience Conference - Roger H Coletti

Roger H Coletti

Interventional Health, PA, United States
Speaker at Neuroscience Conference - Stephen Grossberg

Stephen Grossberg

Boston University, United States
Speaker at Brain Disorders Conference - George Diaz

George Diaz

Memorial Healthcare Systems, United States
Tags

Submit your abstract Today

Watsapp